Clinical Trials

We are currently participating in the following clinical trials:
(Click on trials for additional information from the National Institutes of Health.)

Alzheimer's Disease Immunization Trial - Medication: Bapineuzumab
• Injectable investigation treatment for subjects with mild to moderate Alzheimer’s Disease.

Epilepsy Trial - Medication: Lacosamide
• Treatment for subjects with the diagnosis of epilepsy with simple partial seizures and/or complex partial seizures.

Parkinson's Disease Trial - Medication: Pimavanserin vs. Placebo
• Oral medication for treatment of idiopathic Parkinson’s Disease.

Multiple Sclerosis Trial - Medication: Fingolimod vs. DMT (Disease Modifying Therapy)
• Treatment for relapsing forms of Multiple Sclerosis.

Stroke Trial - Medication: Aspirin vs. Aspirin & Plavix
• National Institutes of Health trial of comparing the benefits of aspirin versus the combination of aspirin and plavix in stroke prevention.

*We anticipate participating in additional clinical trials shortly, so check back soon.